Related Experiment Video

Updated: Aug 8, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.5K

Non-Coding RNA Investigations in Cutaneous Melanoma: A Step forward in Discovering Novel Biomarkers

Simone Ribero1, Martina Lambertini2, Manuela Ferracin3

  • 1Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.

The Journal of Investigative Dermatology
|February 25, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.4K
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

6.5K

Related Experiment Videos

Last Updated: Aug 8, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.5K
A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.4K
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

6.5K

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K

Articles linked to this work by shared authors, journal, and citation graph.

Bracing for the storm: emerging resistance mechanisms to KRAS inhibitors in pancreatic cancer and strategies to overcome them.

Cancer drug resistance (Alhambra, Calif.)·2026

Exploring the Role of TERT Promoter Mutations in Advanced Melanoma Treated With BRAF/MEK Inhibitors or Immune Checkpoint Inhibitors.

Anticancer research·2026

Thin Nevus-Associated Melanoma: Beyond MIA Score Risk Stratification.

Cancers·2026

Circulating tumor cells as biomarkers in melanoma: techniques, challenges, and clinical applications.

Frontiers in cell and developmental biology·2026

Surgical Outcomes of Nonmelanoma Skin Cancer Managed with Systematic Preoperative Reflectance Confocal Microscopy-Guided Margin Assessment: A Retrospective Cohort Study Comparing Wide Local Excision and Mohs Micrographic Surgery.

Diagnostics (Basel, Switzerland)·2026

Towards Accurate Breslow Measurements: Mitigating Issues in Histopathological Imaging.

Entropy (Basel, Switzerland)·2026

Differential BET protein recruitment to IL6 and IL8 promoters and suppression of inflammatory and cell cycle genes by BET inhibitor in keratinocytes.

The Journal of investigative dermatology·2026

Lesional hair lipidomic signatures reveal ARA-LTB4 pathway activation and NETs formation in hidradenitis suppurativa.

The Journal of investigative dermatology·2026

Contact hypersensitivity promotes hair regeneration through SPP1-secreting macrophages.

The Journal of investigative dermatology·2026

Blood proteomics links systemic inflammation with early atherosclerosis in moderate-to-severe atopic dermatitis.

The Journal of investigative dermatology·2026

Defensins Mediate Skin Inflammation and Itch in Psoriasis.

The Journal of investigative dermatology·2026

Divergent cytotoxic and immunomodulatory immune programs distinguish morbilliform drug eruption from SDRIFE.

The Journal of investigative dermatology·2026

Intrinsic AIE drug nanocrystals enable imaging-guided orchitis theranostics.

Materials today. Bio·2026

Photoacoustic Nanotagging for In Vivo Tracking and Optimization of Macrophage Immunotherapy in Solid Tumors.

Advanced materials (Deerfield Beach, Fla.)·2026

Current Advancements of Orally Administered Nanomedicine: Disease Diagnosis and Therapy via Targeted Delivery.

ACS biomaterials science & engineering·2026

Telitacicept for primary angiitis of the central nervous system: A real-world retrospective study.

Therapeutic advances in neurological disorders·2026

Nanotheranostics in orthopedic diseases: a critical review of molecular diagnostic-driven targeted therapeutics for personalized patient care.

Expert review of molecular diagnostics·2026

Limonin ameliorates hyperuricemia-induced cognitive impairment through modulation of microglial HIF-1α-driven neuroinflammation.

International immunopharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us